Ananya Krishna (MC ‘26) studies applied mathematics and chemistry, exploring the power of machine learning, molecular dynamics and computational biochemistry for accelerated drug discovery. She aims to improve global medicine supply and distribution for under-resourced populations, having suffered personal losses due to poor accessibility in India. Her heart lies in the lab, designing and testing nanoparticle malaria vaccines at the National Institutes of Health, pursuing algorithmic molecular docking research at Yale, and developing computational tools for enzyme evolution with GlaxoSmithKline. She has also collaborated with various nonprofits abroad, helping to fund soup kitchens and mobile clinics in Ecuador and Peru, developing online platforms for Maasai women to sell their handcrafts during the pandemic, and packaging books for libraries in Central America.